Clinical considerations of CDK4/6 inhibitors in triple-negative breast cancer
Runtian Wang, Kun Xu, Fangyan Gao, Jinyi Huang, Xiaoxiang Guan
Topics & Concepts
PalbociclibBreast cancerMedicineCell cycleCancer researchOncologyCancerInternal medicineTriple-negative breast cancerMetastatic breast cancerAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchCancer-related Molecular Pathways